IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 171 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $154 | -100.0% | 21,851 | -48.6% | 0.01% | -87.4% |
| Q1 2021 | $1,345,000 | +345.4% | 42,480 | +553.6% | 0.10% | +187.9% |
| Q4 2020 | $302,000 | -51.0% | 6,499 | -65.3% | 0.03% | -68.9% |
| Q3 2020 | $616,000 | +13.2% | 18,711 | -5.6% | 0.11% | +68.3% |
| Q2 2020 | $544,000 | +153.0% | 19,831 | +67.9% | 0.06% | +270.6% |
| Q3 2019 | $215,000 | +117.2% | 11,814 | +13.8% | 0.02% | +183.3% |
| Q1 2019 | $99,000 | -85.5% | 10,385 | -82.9% | 0.01% | -85.7% |
| Q3 2018 | $684,000 | +273.8% | 60,812 | +166.0% | 0.04% | +320.0% |
| Q4 2017 | $183,000 | – | 22,861 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |